Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan Brown

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Medical and Pediatric Oncology|December 24, 1997
Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomasG B McCowage, H S Friedman, A Moghrabi, et al.
Medical and Pediatric Oncology|July 1, 1996
Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamideG McCowage, R Tien, R McLendon, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 6, 2021
A randomized, feasibility trial of an exercise and nutrition-based rehabilitation programme (ENeRgy) in people with cancerCharlie C Hall, Richard J E Skipworth, Honor Blackwood, et al.
Medical and Pediatric Oncology|June 1, 1996
Treatment of patients with pineoblastoma with high dose cyclophosphamideD M Ashley, D Longee, R Tien, et al.
Clinical Nutrition ESPEN|March 14, 2025
Dissecting the global leadership initiative on malnutrition criteria in advanced cancer: Reduced intake vs. inflammationMichael S Yule, Andressa M Machado, Leo R Brown, et al.
Pharmaceutical Research|July 2, 2014
siRNA-mediated knockdown of P450 oxidoreductase in rats: a tool to reduce metabolism by CYPs and increase exposure of high clearance compoundsRob S Burke, Inthirai Somasuntharam, Paul Rearden, et al.
Molecular Therapy. Nucleic Acids|July 21, 2022
Developing antisense oligonucleotides for a <i>TECPR2</i> mutation-induced, ultra-rare neurological disorder using patient-derived cellular modelsLuis A Williams, David J Gerber, Amy Elder, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Medical and Pediatric Oncology|December 24, 1997
Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomasG B McCowage, H S Friedman, A Moghrabi, et al.
Medical and Pediatric Oncology|July 1, 1996
Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamideG McCowage, R Tien, R McLendon, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 6, 2021
A randomized, feasibility trial of an exercise and nutrition-based rehabilitation programme (ENeRgy) in people with cancerCharlie C Hall, Richard J E Skipworth, Honor Blackwood, et al.
Medical and Pediatric Oncology|June 1, 1996
Treatment of patients with pineoblastoma with high dose cyclophosphamideD M Ashley, D Longee, R Tien, et al.
Clinical Nutrition ESPEN|March 14, 2025
Dissecting the global leadership initiative on malnutrition criteria in advanced cancer: Reduced intake vs. inflammationMichael S Yule, Andressa M Machado, Leo R Brown, et al.
Pharmaceutical Research|July 2, 2014
siRNA-mediated knockdown of P450 oxidoreductase in rats: a tool to reduce metabolism by CYPs and increase exposure of high clearance compoundsRob S Burke, Inthirai Somasuntharam, Paul Rearden, et al.
Molecular Therapy. Nucleic Acids|July 21, 2022
Developing antisense oligonucleotides for a <i>TECPR2</i> mutation-induced, ultra-rare neurological disorder using patient-derived cellular modelsLuis A Williams, David J Gerber, Amy Elder, et al.
Pageof 5